trending Market Intelligence /marketintelligence/en/news-insights/trending/D2Ux3aBbBNG8JirCIC5Ugg2 content esgSubNav
In This List

Prana Biotechnology names chief medical officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Prana Biotechnology names chief medical officer

Prana Biotechnology Ltd. appointed David Stamler chief medical officer and senior vice president of clinical development.

Stamler worked at Teva Pharmaceutical Industries Ltd. prior to joining Prana Biotechnology.